ストックスクリーナーアプリを入手
3.99
0.75%
-0.03
プレマーケット:
3.97
-0.02
-0.50%
前日終値:
$4.02
開ける：
$3.95
24時間の取引高:
591.66K
Relative Volume:
0.96
時価総額：
$122.42M
収益：
$875.70K
当期純損益:
$-39.57M
株価収益率:
-2.9725
EPS:
-1.3423
ネットキャッシュフロー:
$-33.65M
1週間 パフォーマンス:
+1.27%
1か月 パフォーマンス:
+0.76%
6か月 パフォーマンス:
+84.72%
1年 パフォーマンス:
+27.88%
1日の値動き範囲:
$3.69
$4.02
1週間の範囲:
$3.69
$4.6499
52週間の値動き範囲:
$1.90
$4.6499
Vistagen Therapeutics Inc Stock (VTGN) Company Profile
名前
Vistagen Therapeutics Inc
セクター
電話
650-577-3600
住所
343 ALLERTON AVENUE, SOUTH SAN FRANCISCO
VTGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VTGN
Vistagen Therapeutics Inc
|
3.99 | 123.34M | 875.70K | -39.57M | -33.65M | -1.3423 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vistagen Therapeutics Inc Stock (VTGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-12-07 | アップグレード | Jefferies | Hold → Buy |
| 2023-08-07 | アップグレード | Maxim Group | Hold → Buy |
| 2022-07-22 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-22 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-07-22 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-05-20 | 開始されました | Robert W. Baird | Outperform |
| 2021-02-18 | 開始されました | Jefferies | Buy |
| 2021-01-04 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2018-06-27 | 開始されました | Maxim Group | Buy |
| 2018-02-08 | 繰り返されました | Chardan Capital Markets | Buy |
| 2017-03-28 | 開始されました | Maxim Group | Buy |
すべてを表示
Vistagen Therapeutics Inc (VTGN) 最新ニュース
Using RSI to spot recovery in Vistagen Therapeutics Inc.Market Activity Report & High Accuracy Investment Signals - newser.com
Is Vistagen Therapeutics Inc. stock attractive for income investorsQuarterly Trade Review & AI Based Buy and Sell Signals - newser.com
Will Vistagen Therapeutics Inc. stock deliver shareholder valueMarket Growth Summary & AI Driven Stock Movement Reports - newser.com
How Vistagen Therapeutics Inc. stock compares to industry benchmarksMarket Sentiment Report & Long-Term Safe Investment Plans - newser.com
Will breakout in Vistagen Therapeutics Inc. lead to full recoveryJuly 2025 Selloffs & Risk Managed Investment Strategies - newser.com
Vistagen Therapeutics Inc. stock trend outlook and recovery pathDip Buying & Daily Market Momentum Tracking - newser.com
Will Vistagen Therapeutics Inc. stock gain from strong economy2025 Risk Factors & Growth-Oriented Investment Plans - newser.com
VistaGen Therapeutics (NASDAQ:VTGN) Share Price Passes Above Fifty Day Moving AverageHere's Why - MarketBeat
Technical signs of recovery in Vistagen Therapeutics Inc.Market Movement Recap & Weekly Market Pulse Alerts - newser.com
Will Vistagen Therapeutics Inc. stock remain a Wall Street favoriteWeekly Trade Summary & Daily Chart Pattern Signals - newser.com
Will Vistagen Therapeutics Inc. stock benefit from green energy trendsNew Guidance & Breakout Confirmation Trade Signals - newser.com
What dividend safety score for Vistagen Therapeutics Inc. stockQuarterly Profit Report & Safe Capital Preservation Plans - newser.com
Is Vistagen Therapeutics Inc. a candidate for recovery play2025 Winners & Losers & Daily Growth Stock Investment Tips - newser.com
Mental Disorder Treatment Market Poised for Boom with Key - openPR.com
What insider trading reveals about Vistagen Therapeutics Inc. stockInsider Buying & Free Community Supported Trade Ideas - fcp.pa.gov.br
Combining machine learning predictions for Vistagen Therapeutics Inc.2025 Valuation Update & Precise Buy Zone Identification - newser.com
Why Vistagen Therapeutics Inc. stock is favored by top institutionsWeekly Gains Summary & Fast Entry and Exit Trade Plans - fcp.pa.gov.br
Can Vistagen Therapeutics Inc. stock deliver surprise earnings beatChart Signals & Fast Exit and Entry Trade Guides - newser.com
Will Vistagen Therapeutics Inc. stock outperform tech sector in 2025Portfolio Profit Report & Daily Chart Pattern Signals - fcp.pa.gov.br
Vistagen (NASDAQ: VTGN) at Stifel Healthcare Conference; chat 3:20–3:50 p.m. ET - Stock Titan
Strategies to average down on Vistagen Therapeutics Inc.2025 Volume Leaders & Weekly Momentum Picks - newser.com
Visualizing Vistagen Therapeutics Inc. stock with heatmapsJuly 2025 Update & Fast Gain Swing Alerts - newser.com
VTGN SEC FilingsVistagen Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
How to recover losses in Vistagen Therapeutics Inc. stockJuly 2025 Catalysts & Weekly Momentum Picks - newser.com
[Form 4] Vistagen Therapeutics, Inc. Insider Trading Activity - Stock Titan
[Form 3] Vistagen Therapeutics, Inc. Initial Statement of Beneficial Ownership - Stock Titan
[8-K] Vistagen Therapeutics, Inc. Reports Material Event | VTGN SEC FilingForm 8-K - Stock Titan
VistaGen Therapeutics: Promising Prospects for Fasedienol in Social Anxiety Disorder - TipRanks
Vistagen Therapeutics (VTGN): Examining Valuation After Phase 3 Trial Progress Toward Social Anxiety Treatment Approval - Yahoo Finance
Published on: 2025-11-04 05:24:21 - newser.com
Is Vistagen Therapeutics Inc. stock reversal real or fakeShare Buyback & Verified Momentum Stock Watchlist - newser.com
How Vistagen Therapeutics Inc. stock compares to growth peersJuly 2025 Fed Impact & High Return Trade Opportunity Guides - fcp.pa.gov.br
Should you hold or exit Vistagen Therapeutics Inc. nowTrade Exit Summary & Trade Opportunity Analysis - newser.com
Vistagen Therapeutics, Inc. (VTGN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Vistagen Therapeutics Inc (VTGN) 財務データ
収益
当期純利益
現金流量
EPS
5.44%
0.70%
大文字化:
|
ボリューム (24 時間):